CEROW
CERo Therapeutics Holdings, Inc. OTC$0.00
Mkt Cap $52,757
52w Low $0.00
44.4% of range
52w High $0.00
50d MA $0.01
200d MA $0.01
P/E (TTM)
0.0x
EV/EBITDA
0.0x
P/B
—
Debt/Equity
-0.1x
ROE
—
P/FCF
-0.0x
RSI (14)
—
ATR (14)
—
Beta
0.24
50d MA
$0.01
200d MA
$0.01
Avg Volume
109.8K
About
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 25, 2026 | AMC | -0.75 | -0.75 | +0.0% | — | — | — | — | — | — | — | — |
| Nov 19, 2025 | AMC | — | -9.10 | — | 0.01 | +7.8% | +7.8% | +1.1% | -54.4% | -32.2% | +1.1% | — |
| Aug 22, 2025 | AMC | -124.26 | -11.10 | +91.1% | 0.02 | +7.8% | +7.8% | +7.3% | +7.8% | +0.6% | +5.0% | — |
| May 15, 2025 | AMC | -75.50 | -1.49 | +98.0% | — | — | — | — | — | — | — | — |
Data updated apr 28, 2026 4:50am
· Source: massive.com